Related Experiment Video
Updated: Apr 18, 2026

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Published on: October 22, 2012
NADPH oxidase p22phox gene expression in ulcerative colitis.
Neşe Bülbül1, Elif Pala, Yusuf Ziya İğci
1Department of Internal Medicine, Nizip State Hospital, Gaziantep, Turkey. drnesebulbul@yahoo.com.tr.
The gene for NADPH oxidase subunit p22phox was not linked to chronic inflammation in ulcerative colitis (UC) patients. Further research is needed to understand oxidative stress mechanisms in UC.
Area of Science:
- Biochemistry
- Molecular Biology
- Gastroenterology
Background:
- Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase generates reactive oxygen species (ROS) crucial for phagocytic cell function.
- Oxidative stress from ROS imbalance contributes to chronic inflammation and may impact ulcerative colitis (UC) pathogenesis.
- The colonic mucosa's integrity is vital in UC, potentially influenced by antioxidant and enzyme dysregulation.
Purpose of the Study:
- To investigate the expression of the NADPH oxidase subunit p22phox gene in the colonic mucosa of UC patients.
- To determine if p22phox gene expression correlates with UC pathogenesis and inflammation.
Main Methods:
- Real-time polymerase chain reaction (PCR) was used to analyze mRNA expression levels.
- Samples were collected from inflamed and non-inflamed colonic mucosa of 22 UC patients and normal mucosa from 22 healthy controls.
- Colonoscopy guided the sample collection from UC patients.
Main Results:
- No significant difference in p22phox mRNA expression was found between inflamed and non-inflamed colonic mucosa in UC patients (p>0.05).
- p22phox mRNA expression levels did not differ significantly between UC patients and healthy controls (p>0.05).
Conclusions:
- The study suggests that p22phox gene expression is not associated with chronic inflammation in ulcerative colitis.
- Other mechanisms likely contribute to oxidative stress in UC patients, warranting further investigation.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease III: Crohn's Disease
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

